Neosporin

Jump to: navigation, search

WikiDoc Resources for

Neosporin

Articles

Most recent articles on Neosporin

Most cited articles on Neosporin

Review articles on Neosporin

Articles on Neosporin in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Neosporin

Images of Neosporin

Photos of Neosporin

Podcasts & MP3s on Neosporin

Videos on Neosporin

Evidence Based Medicine

Cochrane Collaboration on Neosporin

Bandolier on Neosporin

TRIP on Neosporin

Clinical Trials

Ongoing Trials on Neosporin at Clinical Trials.gov

Trial results on Neosporin

Clinical Trials on Neosporin at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Neosporin

NICE Guidance on Neosporin

NHS PRODIGY Guidance

FDA on Neosporin

CDC on Neosporin

Books

Books on Neosporin

News

Neosporin in the news

Be alerted to news on Neosporin

News trends on Neosporin

Commentary

Blogs on Neosporin

Definitions

Definitions of Neosporin

Patient Resources / Community

Patient resources on Neosporin

Discussion groups on Neosporin

Patient Handouts on Neosporin

Directions to Hospitals Treating Neosporin

Risk calculators and risk factors for Neosporin

Healthcare Provider Resources

Symptoms of Neosporin

Causes & Risk Factors for Neosporin

Diagnostic studies for Neosporin

Treatment of Neosporin

Continuing Medical Education (CME)

CME Programs on Neosporin

International

Neosporin en Espanol

Neosporin en Francais

Business

Neosporin in the Marketplace

Patents on Neosporin

Experimental / Informatics

List of terms related to Neosporin

Overview

Neosporin (from Neo, (Greek) new + Sporos, (Greek) seed) is the product name of an antibiotic ointment produced by Pfizer (later sold to Johnson & Johnson) used in the prevention of infection and speeding the healing of wounds. The original ointment contains three different antibiotics: bacitracin, neomycin, and polymyxin B. Other brand names for this mixture include Mycitracin and Topisporin.

Neomycin and polymyxin are effective in killing gram-negative bacteria, while bacitracin targets gram-positive bacteria; hence, this 'triple antibiotic' ointment covers for a wide range of bacteria which may infect wounds.

However, these antibiotics are generally only used topically, because they are known for causing serious side effects (such as nephrotoxicity) when used parenterally. Even when used topically, the antibiotic ointment may cause side effects; in particular, neomycin is well-known for causing allergic reactions such as allergic contact dermatitis. Commonly, though harmlessly, Neosporin tends to exaggerate the pain of abrasions and external injuries.

Neosporin is also used as a brand name for several other U.S. products that do not contain neomycin.

Pfizer also produces a related mixture of bacitracin and polymyxin, branded Polysporin. Because neomycin is not included in Polysporin, Polysporin may be safely used in individuals with allergies to neomycin. Recently, Pfizer also introduced "Neosporin + Pain Relief," ointment and cream, containing pramoxine, a topical analgesic. In addition to its pain relieving properties, the cream (which omits the bacitracin zinc, as it is not stable in the cream base) appears useful in individuals sensitive to bacitracin, as well as those sensitive to zinc.

In Canada, the Neosporin brand is not sold at all, but Polysporin is sold in several varieties. The "original" ointments contain polymyxin B and bacitracin, while the creams and eye/ear drops contain polymyxin B and gramicidin. A "triple" ointment is also available containing all three of the above antibiotics.

External links


Linked-in.jpg